A molecular compound developed by Saint Louis University scientists restored learning, memory and appropriate behavior in a mouse model of Alzheimer’s disease, according to findings in the May issue of the Journal of Alzheimer’s Disease.
The molecule also reduced inflammation in the part of the brain responsible for learning and memory.
The paper, authored by a team of scientists led by Susan Farr, Ph.D., research professor of geriatrics at Saint Louis University, is the second mouse study that supports the potential therapeutic value of an antisense compound in treating Alzheimer’s disease in humans.
“It reversed learning and memory deficits and brain inflammation in mice that are genetically engineered to model Alzheimer’s disease,” Farr said. “Our current findings suggest that the compound, which is called antisense oligonucleotide (OL-1), is a potential treatment for Alzheimer’s disease.”
Farr cautioned that the experiment was conducted in a mouse model. Like any drug, before an antisense compound could be tested in human clinical trials, toxicity tests need to be completed.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- Loveland Police to require training by Alzheimer's Association after excessive force allegationon April 16, 2021 at 8:47 pm
A lawsuit claims Karen Garner suffered a dislocated shoulder, a broken humerus and a sprained wrist during the June 2020 arrest.
- Ocala woman dedicated to helping Alzheimer's and dementia patients/familieson April 16, 2021 at 9:38 am
Mikaela Saunderson has found her life's calling: helping patients/families as they work through Alzheimer's disease and dementia.
- How a tangled protein kills brain cells, promotes Alzheimer'son April 16, 2021 at 7:53 am
Look deep inside the brain of someone with Alzheimer's disease, most forms of dementia or the concussion-related syndrome known as chronic traumatic encephalopathy (CTE) and you'll find a common ...
- Your Alzheimer's Disease Risk May Depend on Where You Liveon April 16, 2021 at 6:39 am
Residents of worse-off neighborhoods may be more at risk of ‘brain shrinkage’ and dementia, according to a new study.
- How Heavy Drinking May Cause Alzheimer's Diseaseon April 16, 2021 at 6:27 am
It’s becoming increasingly clear that people who drink heavily are more likely to develop Alzheimer's disease, but the exact nature of this link has remain ...
- Mouse Model of Alzheimer’s Reveals Some Plaques May Defend and Not Destroyon April 16, 2021 at 5:00 am
New research has found that dense-core plaques play a protective role and may serve as a defense mechanism in mouse model of Alzheimer's disease.
- Alzheimer’s Drugs Market Research, Business Opportunity, Global Trend, Future Growth, Key Findings and Forecast to 2027on April 15, 2021 at 11:05 pm
Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027, Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer’s drugs which in turn is driving the ...
- Brain cells derived from Alzheimer’s disease patients have multiple specific innate abnormalities in energy metabolismon April 15, 2021 at 10:21 pm
Altered energy metabolism has been implicated both in aging and the pathogenesis of late-onset Alzheimer’s disease (LOAD). However, it is unclear which anomalies are acquired phenotypes and which are ...
- Hypoxia compromises the mitochondrial metabolism of Alzheimer’s disease microglia via HIF1on April 15, 2021 at 10:45 am
Microglia can help clear amyloid β plaques in the Alzheimer’s disease brain but may also become dysfunctional and can contribute to disease progression. March-Diaz et al. reveal that hypoxia, a ...
- Understanding Alzheimer's and Dementiaon April 15, 2021 at 9:33 am
Dr. Morgan Sauer with Baptist Health Systems joins Theba Lolley for a conversation about understanding terminology associated with Alzheimer's and Dementia.
via Bing News